Study of 5'UTR Mutations in Prostate Cancer
Disease Events (12)
- AFFECTION_STATUS - Case control status of the subject for prostate cancer (phv00407307.v1.p1)
- Age_at_Diagnosis - Age at diagnosis in years (phv00407315.v1.p1)
- Androgen deprivation therapy - Type of tumor treatment for sample (phv00407327.v1.p1)
- Gl_of_Primary_CaP - GI of primary Cancer of Prostate (CaP) if available (phv00407312.v1.p1)
- IS_TUMOR - Tumor status (phv00407321.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Presence or absence of metastasis (phv00407323.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00407324.v1.p1)
- PSA_at_Ddx - PSA levels at diagnosis (phv00407314.v1.p1)
- Stage - Cancer stage of patient (phv00407313.v1.p1)
- survival_from_dx - Survival in years from diagnosis (phv00407317.v1.p1)
- TUMOR_Gleason index - Tumor grade of sample (phv00407326.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00407325.v1.p1)
Race and Ethnicity (1)
- Race - Race of patient (phv00407311.v1.p1)
Other (12)
- Age_at_death - Age at death in years (phv00407316.v1.p1)
- ANALYTE_TYPE - Type of analyte (phv00407320.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00407319.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00407306.v1.p1)
- GENOTYPING_CENTER - Name of the center which conducted genotyping (phv00407328.v1.p1)
- HISTOLOGICAL_TYPE - Body site where sample was collected (phv00407322.v1.p1)
- SAMPLE_ID - De-identified Sample ID (phv00407318.v1.p1)
- SAMPLE_ID - Sample ID (phv00407309.v1.p1)
- SEQUENCING_CENTER - Name of the center which conducted sequencing (phv00407329.v1.p1)
- SUBJECT_ID - De-identified Subject ID (phv00407310.v1.p1)
- SUBJECT_ID - Subject ID (phv00407305.v1.p1)
- SUBJECT_ID - Subject ID (phv00407308.v1.p1)